NCT00748085View on ClinicalTrials.gov

CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)

NATerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

August 31, 2009

Conditions
Lung CancerMesothelioma
Interventions
DEVICE

CryoSpray Ablation

Treatment dosimetry will be up to 4, 5-second spray cycles. Subjects will have initial cryospray treatment. Subjects may undergo up to one bronchoscopy with CryoSpray Ablation every seven days for a total of four (4) treatments in the first month.

Trial Locations (1)

21237

Franklin Square Hospital Center, Baltimore

Sponsors

Lead Sponsor

CSA Medical, Inc.
All Listed Sponsors
lead

CSA Medical, Inc.

INDUSTRY